Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Aug-24 4:05 PM View:  | Biora Therapeutics, Inc. (BIOR) | 15-Aug-24 | Payment of Exercise | 27,830 | $0.67 | $18,646.10 | (5%) 603.66K to 575.83K | |
| 15-Feb-24 4:05 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Feb-24 | Grant | 325,000 | -- | -- | 117% 278.66K to 603.66K | |
| 17-Aug-23 4:22 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Grant | 219,650 | -- | -- | 222% 99.03K to 318.68K | |
| 17-Aug-23 4:22 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Aug-23 | Payment of Exercise | 40,022 | $3.14 | $125,669.00 | (13%) 318.68K to 278.66K | |
| 17-May-23 4:56 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-May-23 | Payment of Exercise | 2,807 | $3.35 | $9,403.45 | (3%) 101.84K to 99.03K | |
| 17-Mar-23 9:16 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Grant | 84,917 | -- | -- | 302% 28.14K to 113.06K | |
| 17-Mar-23 9:16 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Mar-23 | Payment of Exercise | 11,216 | $2.56 | $28,713.00 | (10%) 113.06K to 101.84K | |
| 17-Feb-23 4:15 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Feb-23 | Payment of Exercise | 269 | $3.46 | $930.74 | (< 1%) 28.41K to 28.14K | |
| 05-Jan-23 4:05 PM View: | Biora Therapeutics, Inc. (BIOR) | 03-Jan-23 | Disposition | 95 | -- | -- | (100%) 95 to 0 | |
| 16-Nov-22 9:48 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Nov-22 | Payment of Exercise | 5,194 | $0.27 | $1,402.38 | (< 1%) 715.32K to 710.12K | |
| 16-Aug-22 5:58 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Aug-22 | Payment of Exercise | 5,952 | $1.04 | $6,190.08 | (< 1%) 714.38K to 708.43K | |
| 17-May-22 5:18 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-May-22 | Grant | 292,406 | -- | -- | 69% 423.17K to 715.58K | |
| 17-May-22 5:18 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-May-22 | Payment of Exercise | 10,387 | $0.75 | $7,790.25 | (1%) 715.58K to 705.19K | |
| 19-Apr-22 4:23 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Apr-22 | Grant | 231,693 | -- | -- | 121% 191.48K to 423.17K | |
| 17-Feb-22 4:05 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Feb-22 | Payment of Exercise | 4,919 | $1.90 | $9,346.10 | (3%) 196.4K to 191.48K | (< 1%) |
| 17-Aug-21 4:00 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Aug-21 | Payment of Exercise | 5,718 | $1.66 | $9,491.88 | (3%) 202.12K to 196.4K | 5% |
| 19-Apr-21 9:32 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Apr-21 | Grant | 123,382 | -- | -- | 133% 92.42K to 215.81K | |
| 19-Apr-21 9:32 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Apr-21 | Payment of Exercise | 13,690 | $3.41 | $46,682.90 | (6%) 215.81K to 202.12K | 22% |
| 08-Mar-21 5:14 PM View: | Biora Therapeutics, Inc. (BIOR) | 04-Mar-21 | Payment of Exercise | 1,608 | $4.05 | $6,512.40 | (2%) 94.03K to 92.42K | 35% |
| 17-Feb-21 5:04 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Feb-21 | Payment of Exercise | 5,361 | $5.60 | $30,021.60 | (5%) 99.39K to 94.03K | 53% |
| 22-Dec-20 7:19 PM View: | Biora Therapeutics, Inc. (BIOR) | 19-Dec-20 | Payment of Exercise | 1,228 | $6.32 | $7,760.96 | (1%) 100.62K to 99.39K | |
| 18-Aug-20 9:42 PM View: | Biora Therapeutics, Inc. (BIOR) | 15-Aug-20 | Grant | 36,243 | -- | -- | 56% 64.38K to 100.62K | |
| 22-May-18 7:53 PM View: | Theravance Inc. (INVA) | 21-May-18 | Market Sale | 5,808 | $14.40 | $83,623.00 | (2%) 378.89K to 373.08K | 14% |
| 22-May-18 7:53 PM View: | Theravance Inc. (INVA) | 20-May-18 | Payment of Exercise | 7,901 | $14.59 | $115,276.00 | (2%) 384.87K to 376.96K | 15% |
| 06-Mar-18 4:14 PM View: | Theravance Inc. (INVA) | 02-Mar-18 | Grant | 93,056 | -- | -- | 32% 291.81K to 384.87K | |
| 22-Feb-18 4:24 PM View: | Theravance Inc. (INVA) | 21-Feb-18 | Market Sale (Planned) | 5,378 | $16.52 | $88,825.20 | (2%) 297.19K to 291.81K | 25% |
| 22-Feb-18 4:24 PM View: | Theravance Inc. (INVA) | 20-Feb-18 | Payment of Exercise | 24,876 | $16.44 | $408,961.00 | (8%) 322.06K to 297.19K | 25% |
| 22-Nov-17 4:51 PM View: | Theravance Inc. (INVA) | 21-Nov-17 | Market Sale (Planned) | 13,460 | $13.31 | $179,171.00 | (4%) 335.2K to 321.74K | 7% |
| 22-Nov-17 4:51 PM View: | Theravance Inc. (INVA) | 20-Nov-17 | Payment of Exercise | 6,141 | $13.17 | $80,877.00 | (2%) 343.17K to 337.03K | 6% |
| 22-Nov-17 4:51 PM View: | Theravance Inc. (INVA) | 20-Nov-17 | Market Sale (Planned) | 1,825 | $13.04 | $23,798.00 | (< 1%) 337.03K to 335.2K | 5% |
| 22-Aug-17 4:37 PM View: | Theravance Inc. (INVA) | 21-Aug-17 | Market Sale (Planned) | 1,825 | $12.20 | $22,265.00 | (< 1%) 344.99K to 343.17K | (1%) |
| 22-Aug-17 4:37 PM View: | Theravance Inc. (INVA) | 20-Aug-17 | Payment of Exercise | 5,770 | $12.28 | $70,855.60 | (2%) 350.76K to 344.99K | (< 1%) |
| 23-May-17 4:15 PM View: | Theravance Inc. (INVA) | 22-May-17 | Market Sale (Planned) | 1,825 | $11.85 | $21,626.20 | (< 1%) 352.59K to 350.76K | (4%) |
| 23-May-17 4:15 PM View: | Theravance Inc. (INVA) | 20-May-17 | Payment of Exercise | 4,208 | $11.86 | $49,906.90 | (1%) 356.8K to 352.59K | (4%) |
| 22-Feb-17 4:30 PM View: | Theravance Inc. (INVA) | 21-Feb-17 | Market Sale (Planned) | 1,825 | $12.07 | $22,027.80 | (< 1%) 356.12K to 354.3K | (2%) |
| 22-Feb-17 4:30 PM View: | Theravance Inc. (INVA) | 20-Feb-17 | Payment of Exercise | 8,604 | $12.04 | $103,592.00 | (2%) 364.73K to 356.12K | (3%) |
| 19-Jan-17 8:22 PM View: | Theravance Inc. (INVA) | 17-Jan-17 | Grant | 133,398 | -- | -- | 58% 231.33K to 364.73K | |
| 22-Nov-16 5:45 PM View: | Theravance Inc. (INVA) | 21-Nov-16 | Market Sale (Planned) | 1,800 | $10.89 | $19,602.00 | (< 1%) 233.13K to 231.33K | (13%) |
| 22-Nov-16 5:45 PM View: | Theravance Inc. (INVA) | 20-Nov-16 | Payment of Exercise | 3,832 | $10.91 | $41,807.10 | (2%) 236.96K to 233.13K | (13%) |
| 23-Aug-16 6:56 PM View: | Theravance Inc. (INVA) | 22-Aug-16 | Market Sale (Planned) | 3,700 | $11.77 | $43,549.00 | (2%) 239.89K to 236.19K | (5%) |
| 23-Aug-16 6:56 PM View: | Theravance Inc. (INVA) | 20-Aug-16 | Payment of Exercise | 2,845 | $11.79 | $33,542.60 | (1%) 242.74K to 239.89K | (5%) |
| 20-May-16 7:52 PM View: | Theravance Inc. (INVA) | 20-May-16 | Payment of Exercise | 2,818 | $11.09 | $31,251.60 | (1%) 245.56K to 242.74K | (11%) |
| 23-Feb-16 6:56 PM View: | Theravance Inc. (INVA) | 19-Feb-16 | Payment of Exercise | 5,457 | $12.28 | $67,012.00 | (2%) 248.51K to 243.06K | (< 1%) |
| 19-Jan-16 4:08 PM View: | Theravance Inc. (INVA) | 14-Jan-16 | Grant | 115,734 | -- | -- | 87% 132.78K to 248.51K | |
| 23-Nov-15 6:14 AM View: | Theravance Inc. (INVA) | 20-Nov-15 | Payment of Exercise | 7,940 | $8.92 | $70,824.80 | (6%) 140.72K to 132.78K | (38%) |
| 09-Jan-15 4:32 PM View: | Theravance Inc. (INVA) | 07-Jan-15 | Grant | 36,972 | -- | -- | 36% 102.47K to 139.44K | |
| 17-Oct-14 4:30 PM View: | Theravance Inc. (INVA) | 16-Oct-14 | Grant | 102,471 | -- | -- | 100% 0 to 102.47K |